Skip to main content
. Author manuscript; available in PMC: 2018 Nov 1.
Published in final edited form as: Pharmacol Ther. 2017 May 18;179:1–16. doi: 10.1016/j.pharmthera.2017.05.002

Table 3.

Clinical trial

Intervention Condition ClinicalTrials.gov Identifier
VNS vs prucalopride Postoperative ileus NCT02425774
VNS Crohn’s disease NCT02311660
NCT02951650
NCT01569503
Transcutaneous VNS Irritable bowel syndrome NCT02420158
VNS Rheumatoid arthritis NCT01552941
NCT01552538
Galantamine Metabolic syndrome NCT02283242
Transcutaneous VNS Systemic Lupus
Musculoskeletal Pain
NCT02822989
Neostigmine methylsulfate Raceanisodamine HCl Prevent/treat SIRS* NCT02279147
*

SIRS, systemic inflammatory response syndrome